Oncogenex Pharmaceuticals, Inc.
Records under this name other than patents Oncogenex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Oncogenex Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,493,500 | Fluorinated pyrimidine analogs and methods of use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,982,282 | Emulsion vehicle for poorly soluble drugs Formerly held Term ended Term ended Sep 24, 2018 · From the USPTO record | Term ended | Term ended Sep 24, 2018 | From the USPTO record |
| US 7,030,155 | Emulsion vehicle for poorly soluble drugs Formerly held Lapsed on the fee record Ended Apr 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2018 | From the USPTO record |
| US 6,458,373 | Emulsion vehicle for poorly soluble drugs Formerly held Term ended Term ended Jan 5, 2018 · From the USPTO record | Term ended | Term ended Jan 5, 2018 | From the USPTO record |
| US 6,727,280 | Method for treating colorectal carcinoma using a taxane/tocopherol formulation Formerly held Lapsed on the fee record Ended Apr 27, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 27, 2012 | From the USPTO record |